R. M. Steinman, M. Pack, and K. Inaba, Dendritic Cell Development and Maturation, Atherosclerosis, vol.417, pp.1-6, 1997.

R. M. Steinman, The control of immunity and tolerance by dendritic cell, Pathol. Boil, vol.51, pp.59-60, 2003.

A. Boltjes and F. Van-wijk, Human Dendritic Cell Functional Specialization in Steady-State and Inflammation, Front. Immunol, vol.5, 2014.

R. M. Steinman, S. Turley, I. Mellman, and K. Inaba, The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells, J. Exp. Med, vol.191, pp.411-416, 2000.

F. Coutant and P. Miossec, Altered dendritic cell functions in autoimmune diseases: Distinct and overlapping profiles, Nat. Rev. Rheumatol, vol.12, pp.703-715, 2016.

M. Sadeghzadeh, S. Bornehdeli, H. Mohahammadrezakhani, M. Abolghasemi, E. Poursaei et al., Dendritic cell therapy in cancer treatment; the state-of-the-art, Life Sci, vol.2020, 117580.

S. Balan, M. Saxena, and N. Bhardwaj, Dendritic cell subsets and locations, Int. Rev. Cell Mol. Biol, vol.348, pp.1-68, 2019.

M. Collin and V. Bigley, Human dendritic cell subsets: An update, Immunology, vol.154, pp.3-20, 2018.

M. Collin and P. Milne, Langerhans cell origin and regulation, Curr. Opin. Hematol, vol.23, pp.28-35, 2016.

E. Segura and S. Amigorena, Inflammatory dendritic cells in mice and humans, Trends Immunol, vol.34, pp.440-445, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00846095

B. León, M. López-bravo, and C. Ardavín, Monocyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania. Immun, vol.26, pp.519-531, 2007.

S. Tartey and O. Takeuchi, Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells, Int. Rev. Immunol, vol.36, pp.57-73, 2017.

A. Masuda, M. Yoshida, H. Shiomi, Y. Morita, H. Kutsumi et al., Role of Fc Receptors as a therapeutic target, Inflamm. Allergy Drug Targets, vol.8, pp.80-86, 2009.

P. Bruhns and F. Jönsson, Mouse and human FcR effector functions, Immunol. Rev, vol.268, pp.25-51, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01281740

L. D. Oliveira-nascimento, P. Massari, and L. M. Wetzler, The Role of TLR2 in Infection and Immunity. Front

S. Dillon, S. Agrawal, K. Banerjee, J. Letterio, T. Denning et al., Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance, J. Clin. Investig, vol.116, pp.916-928, 2006.

D. De-nardo, Toll-like receptors: Activation, signalling and transcriptional modulation, Cytokine, vol.74, pp.181-189, 2015.

G. Brown, J. Willment, and L. Whitehead, C-type lectins in immunity and homeostasis, Nat. Rev. Immunol, vol.18, pp.374-389, 2018.

T. B. Geijtenbeek, S. J. Van-vliet, A. Engering, B. A. Hart, and Y. Van-kooyk, Self-and Nonself-Recognition by C-Type Lectins on Dendritic Cells, Annu. Rev. Immunol, vol.22, pp.33-54, 2004.

A. Cambi and C. G. Figdor, Dual function of C-type lectin-like receptors in the immune system, Curr. Opin. Cell Biol, vol.15, pp.539-546, 2003.

D. Sancho and C. R. Sousa, Signaling by myeloid C-type lectin receptors in immunity and homeostasis, Annu. Rev. Immunol, vol.30, pp.491-529, 2012.

F. Meyer-wentrup, D. Benitez-ribas, P. J. Tacken, C. J. Punt, C. G. Figdor et al., Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-? production, Blood, vol.111, pp.4245-4253, 2008.

N. ;. Van-montfoort, P. Ac't-hoen, S. M. Mangsbo, M. G. Camps, P. Boross et al., Fc? Receptor IIb Strongly Regulates Fc Receptor-Facilitated T Cell Activation by Dendritic Cells, J. Immunol, vol.189, pp.92-101, 2012.

M. Guilliams, P. Bruhns, Y. Saeys, H. Hammad, and B. N. Lambrecht, The function of Fc? receptors in dendritic cells and macrophages, Nat. Rev. Immunol, vol.14, pp.94-108, 2014.

U. Bave, M. Magnusson, M. Eloranta, A. Perers, G. V. Alm et al., Fc RIIa Is Expressed on Natural IFN--Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-Production Induced by Apoptotic Cells Combined with Lupus IgG, J. Immunol, vol.171, pp.3296-3302, 2003.

T. Döbel, Fc?RIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens, BloodJ. Am. Soc. Hematol, vol.121, pp.3609-3618, 2013.

A. Pellerin, K. Otero, J. M. Czerkowicz, H. M. Kerns, R. I. Shapiro et al., Anti-BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms, Embo Mol. Med, vol.7, pp.464-476, 2015.

K. Baker, T. Rath, M. Pyzik, and R. S. Blumberg, The Role of FcRn in Antigen Presentation, Front. Immunol, vol.5, 2014.

K. Baker, S. Qiao, T. T. Kuo, V. G. Aveson, B. Platzer et al., Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells, Proc. Natl. Acad. Sci, vol.108, pp.9927-9932, 2011.

M. B. Yu and W. H. Langridge, The function of myeloid dendritic cells in rheumatoid arthritis, Rheumatol. Int, vol.37, pp.1043-1051, 2017.

C. Qian and X. Cao, Dendritic cells in the regulation of immunity and inflammation, Semin. Immunol, vol.35, pp.3-11, 2018.

R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, Tolerogenic dendritic cells, Annu. Rev. Immunol, vol.21, pp.685-711, 2003.

K. Sato, T. Uto, T. Fukaya, and H. Takagi, Regulatory Dendritic Cells, Curr. Top. Microbiol. Immunol, vol.410, pp.47-71, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01438515

M. A. Boks, J. R. Kager-groenland, M. S. Haasjes, J. J. Zwaginga, and S. M. Van-ham, Ten Brinke, A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-A comparative study of human clinical-applicable DC, Clin. Immunol, vol.142, pp.332-342, 2012.

P. Monti, M. Scirpoli, P. Maffi, L. Piemonti, A. Secchi et al., Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4 + CD25 + FOXP3 + Regulatory T-Cells. Diabetes, vol.57, pp.2341-2347, 2008.

M. Quante, T. Heinbokel, K. Edtinger, K. Minami, H. Uehara et al., Rapamycin Prolongs Graft Survival and Induces CD4+IFN-?+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice, Transplantation, vol.102, pp.59-69, 2018.

Y. Liu, Y. Chen, F. Q. Liu, J. R. Lamb, and P. K. Tam, Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation, Transpl. Int, vol.21, pp.483-494, 2008.

J. Yang, L. Liu, Y. Yang, N. Kong, X. Jiang et al., Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis, J. Immunol. Res, pp.1-13, 2017.

L. N. Paiatto, F. Silva, A. T. Yamada, W. M. Tamashiro, and P. U. Simioni, Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice, PLoS ONE, vol.13, 2018.

I. Tabansky, D. B. Keskin, D. Watts, C. Petzold, M. Funaro et al., Mol. Med, vol.24, 2018.

M. J. Xia, J. Shan, Y. P. Li, Y. Zhou, Y. J. Guo et al., Adoptive transfusion of tolerant dendritic cells prolong the survival of renal allografts: A systematic review, J. Evid. Based Med, vol.6, pp.250-264, 2013.

D. Tokita, G. V. Mazariegos, A. F. Zahorchak, N. Chien, M. Abe et al., High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance, Transplantation, vol.85, pp.369-377, 2008.

S. Kim, H. Jung, C. Lee, and . Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells, Yonsei Med. J, vol.59, pp.807-815, 2018.

B. Willekens, S. Presas-rodríguez, M. J. Mansilla, J. Derdelinckx, W. Lee et al., Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration, BMJ Open, vol.9, 2019.

G. M. Bell, A. E. Anderson, J. Diboll, R. Reece, O. Eltherington et al., Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis, Ann. Rheum. Dis, vol.76, pp.227-234, 2016.

A. Jauregui-amezaga, R. Cabezón, A. Ramírez-morros, C. España, J. Rimola et al., Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study, J. CrohnS Colitis, vol.9, pp.1071-1078, 2015.

E. K. Geissler, The ONE Study compares cell therapy products in organ transplantation: Introduction to a review series on suppressive monocyte-derived cells, Transplant. Res, 2012.

J. Ostrop and R. Lang, Contact, Collaboration, and Conflict: Signal Integration of Syk-Coupled C-Type Lectin Receptors, J. Immunol, vol.198, pp.1403-1414, 2017.

I. Hirsch, V. Janovec, and R. Stranska, Bendriss-Vermare, N. Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells, Front. Immunol, vol.8, 2017.

A. Dragicevic, T. Dzopalic, S. Vasilijic, D. Vucevic, S. Tomi? et al., Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses, Cytotherapy, vol.14, pp.598-607, 2012.

M. E. Eberle and A. H. Dalpke, Dectin-1 Stimulation Induces Suppressor of Cytokine Signaling 1, Thereby Modulating TLR Signaling and T Cell Responses, J. Immunol, vol.188, pp.5644-5654, 2012.

K. M. Dennehy, J. Willment, D. L. Williams, and G. Brown, Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways, Eur. J. Immunol, vol.39, pp.1379-1386, 2009.

E. Mortaz, I. M. Adcock, P. Tabarsi, M. Masjedi, D. Mansouri et al., Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis, J. Clin. Immunol, vol.35, pp.1-10, 2014.

S. E. Hardison and G. Brown, C-type lectin receptors orchestrate antifungal immunity, Nat. Immunol, vol.13, pp.817-822, 2012.

A. Plato, S. E. Hardison, and G. Brown, Pattern recognition receptors in antifungal immunity, Semin. Immunopathol, vol.37, pp.97-106, 2014.

T. B. Geijtenbeek, J. D. Dunnen, and S. Gringhuis, Pathogen recognition by DC-SIGN shapes adaptive immunity, Futur. Microbiol, vol.4, pp.879-890, 2009.

T. B. Geijtenbeek, S. J. Van-vliet, E. A. Koppel, M. Sanchez-hernandez, C. M. Vandenbroucke-grauls et al., Faculty Opinions recommendation of Mycobacteria target DC-SIGN to suppress dendritic cell function, Fac. Opin. Post Publ. Peer Rev. Biomed. Lit, vol.197, pp.7-17, 2003.

F. Meyer-wentrup, A. Cambi, B. Joosten, M. W. Looman, I. J. De-vries et al., DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production, J. Leukoc. Boil, vol.85, pp.518-525, 2008.

Y. Pan, Y. Yu, C. Lin, L. L. Lanier, and C. Chu, Fc?RI ?-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells, Front. Immunol, vol.8, 1424.

L. T. Vogelpoel, I. S. Hansen, M. W. Visser, S. Q. Nagelkerke, T. W. Kuijpers et al., Fc?RIIa cross-talk with TLRs, IL-1R, and IFN?R selectively modulates cytokine production in human myeloid cells, Immunobiology, vol.220, pp.193-199, 2015.

B. M. Neves, M. C. Lopes, and M. T. Cruz, Pathogen Strategies to Evade Innate Immune Response: A Signaling Point of View, pp.123-164, 2012.

D. Feng, Y. Wang, Y. Liu, L. Wu, X. Li et al., DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-?B activation in renal tubular epithelial cells during acute renal injury: DC-SIGN/TLR-4 regulates NF-?B activation, Clin. Exp. Immunol, vol.191, pp.107-115, 2018.

L. Balboa, M. M. Romero, N. Yokobori, P. Schierloh, L. Geffner et al., Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile, Immunol. Cell Boil, vol.88, pp.716-726, 2010.

B. N. Gantner, R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill, Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2, J. Exp. Med, vol.197, pp.1107-1117, 2003.

R. S. Tan, B. Ho, B. P. Leung, and J. L. Ding, TLR Cross-talk Confers Specificity to Innate Immunity, Int. Rev. Immunol, vol.33, pp.443-453, 2014.

L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M. C. Nussenzweig et al., Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance, J. Exp. Med, vol.196, pp.1627-1638, 2002.

S. Yamazaki, D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito et al., CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells1, J. Immunol, vol.181, pp.6923-6933, 2008.

J. Idoyaga, C. Cheong, K. Suda, N. Suda, J. Y. Kim et al., Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo, J. Immunol, vol.180, pp.3647-3650, 2008.

C. H. Lehmann, L. Heger, G. F. Heidkamp, A. Baranska, J. J. Lühr et al., Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
URL : https://hal.archives-ouvertes.fr/hal-01438144

L. Peyrin-biroulet, S. Demarest, and A. Nirula, Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies, Autoimmun. Rev, vol.18, pp.123-128, 2019.

C. Dumet, J. Pottier, V. Gouilleux, and H. Watier, New structural formats of therapeutic antibodies for rheumatology, Jt. Bone Spine, vol.85, pp.47-52, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02414904

C. Spiess, Q. Zhai, and P. J. Carter, Alternative molecular formats and therapeutic applications for bispecific antibodies, Mol. Immunol, vol.67, pp.95-106, 2015.

R. E. Kontermann, U. Brinkmann, and . Bispecific, Drug Discov. Today, vol.20, pp.838-847, 2015.

H. Kaplon, M. Muralidharan, Z. Schneider, and J. M. Reichert, Antibodies to watch in 2020, vol.12, pp.183-203, 2019.

F. Koch-nolte, Novel biologics targeting the P2X7 ion channel, Curr. Opin. Pharmacol, vol.47, pp.110-118, 2019.

M. Godar, K. Deswarte, K. Vergote, M. Saunders, H. De-haard et al., A bispecific antibody strategy to target multiple type 2 cytokines in asthma, J. Allergy Clin. Immunol, vol.142, pp.1185-1193, 2018.

P. Fournier and V. Schirrmacher, Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future, BioDrugs, vol.27, pp.35-53, 2013.

L. Xu, A. Pegu, E. Rao, N. A. Doria-rose, J. Beninga et al., Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques, vol.358, pp.85-90, 2017.

X. Wu, R. Yuan, M. Bacica, and S. J. Demarest, Generation of orthogonal Fab-based trispecific antibody formats, Protein Eng. Des. Sel, vol.31, pp.249-256, 2018.

T. Gantke, M. Weichel, C. Herbrecht, U. Reusch, K. Ellwanger et al., Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells, Protein Eng. Des. Sel, vol.30, pp.673-684, 2017.

X. Wu and S. J. Demarest, Building blocks for bispecific and trispecific antibodies, Methods, vol.154, pp.3-9, 2019.

J. J. Steinhardt, J. Guenaga, H. L. Turner, K. Mckee, M. K. Louder et al., Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity, Nat. Commun, vol.9, pp.1-12, 2018.